Skip to main content
. Author manuscript; available in PMC: 2021 Jul 7.
Published in final edited form as: Psychiatr Serv. 2020 Dec 3;72(2):148–155. doi: 10.1176/appi.ps.202000049

FIGURE 1. Difference-in-differences (DID) regression results estimating the effect of Medicaid expansion on the number of opioid treatment programs (OTPs) in a state per 100,000 populationa.

FIGURE 1.

a All models were conducted with the xtreg command in Stata, version 15, with standard errors clustered at the state level and with control for optional and mandatory-access prescription drug monitoring programs, pain clinic laws, state median income, state age distribution, state race-ethnicity, state poverty and unemployment rates, and state and year fixed effects.

b Extended-release injectable naltrexone.

c DID coefficients (change in number of programs per 100,000 population after Medicaid expansion). Shaded areas indicate 95% confidence intervals.